STAT

Opinion: Privacy laws are hurting the care of patients with addiction

I need to communicate with my opioid use disorder patients's other clinicians. The law sometimes thwarts me from doing that.
University of Massachusetts Medical School nursing student Morgan Brescia attends a simulation of treatment for a patient coping with addiction during class at the medical school in Worcester, Mass.

When my grandfather was a private practice pediatrician in Queens, making house calls in exchange for eggs and hand-knitted hats, medical communications were often between one doctor and his or her patient (or parent). As a primary care provider to adults with opioid use disorder, I need to communicate with many other clinicians. Privacy rules can thwart me from doing that.

The U.S. medical system has changed dramatically in the past century, creating complicated structures that

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks